[1]
Rahman MH, Akter R, Behl T, et al. COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy. Curr Pharm Des 2020; 26(41): 5224-40.
[2]
Shawon J, Akter Z, Hossen MM, et al. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism. Curr Pharm Des 2020; 26(41): 5241-60.
[3]
Wilkin P, Al-Yozbaki M, George A, Gupta GK, Wilson C. The Undiscovered Potential of Essential Oils for Treating SARS-CoV-2 (COVID-19). Curr Pharm Des 2020; 26(41): 5261-77.
[4]
Pamuru RR, Ponneri N, Damu AG, Vadde R. Targeting Natural Products for the Treatment of COVID-19 – An Updated Review. Curr Pharm Des 2020; 26(41): 5278-85.
[5]
Sohrab SS, Suhail M, Kamal MA, Ahmad F, Azhar EI. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2. Curr Pharm Des 2020; 26(41): 5286-92.
Current Pharmaceutical Design
Title:Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part-I)
Volume: 26 Issue: 41
Author(s): Mohammad Amjad Kamal and Md. Asaduzzaman Khan
Affiliation:
Export Options
About this article
Cite this article as:
Kamal Amjad Mohammad and Khan Asaduzzaman Md., Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part-I), Current Pharmaceutical Design 2020; 26 (41) . https://dx.doi.org/10.2174/138161282641201126124050
DOI https://dx.doi.org/10.2174/138161282641201126124050 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
24
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multivalent Vancomycins and Related Antibiotics Against Infectious Diseases
Current Pharmaceutical Design COVID-19 Induces Cytokine Storm and Dysfunctional Hemostasis
Current Drug Targets Predicting Dopamine Receptors Binding Affinity of N-[4-(4-Arylpiperazin- 1-yl) butyl]Aryl Carboxamides: Computational Approach Using Topological Descriptors
Current Drug Discovery Technologies High Throughput Bioassays Using Nanoparticles
Combinatorial Chemistry & High Throughput Screening Integrated Ligand Based Pharmacophore Model Derived from Diverse FAAH Covalent Ligand Classes
Current Computer-Aided Drug Design Benzothiazoles: How Relevant in Cancer Drug Design Strategy?
Anti-Cancer Agents in Medicinal Chemistry The Chemical Structure and Bioactivity of Cycloartane-type Compounds
Current Organic Chemistry Administration of Exogenous Surfactant and Cytosolic Phospholipase A2α Inhibitors may Help COVID-19 Infected Patients with Chronic Diseases
Coronaviruses Seeds as a Production System for Molecular Pharming Applications: Status and Prospects
Current Pharmaceutical Design Recent Developments in the Synthesis of Nicotinic Acetylcholine Receptor Ligands
Current Topics in Medicinal Chemistry QT Interval Monitoring and Drugs Management During COVID-19 Pandemic
Current Reviews in Clinical and Experimental Pharmacology Synthesis and Biological Activity of 2,7-Naphthyridine Derivatives: An Overview
Current Organic Chemistry The Plastic and Functional Changes in Hippocampal Neurons During Pregnancy, Delivery and Postpartum are Reversed by Offspring Deprivation
Current Psychopharmacology Sarcoidosis and Sarcoid Reactions in Endometrial Cancer Cases Masquerading Advanced Stage Malignancy
Current Women`s Health Reviews Protein-Ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2
Current Medicinal Chemistry Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews The Synthetic Potential and Chemical Aspects of the Gewald Reaction: Application in the Preparation of 2-Aminothiophenes and Related Heterocycles
Current Organic Synthesis Genetics and Vaccine Development for SARS-CoV2 in the Era of Personalized Medicine
Infectious Disorders - Drug Targets VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Current Cancer Drug Targets Rational Design of Antimalarial Drugs Using Molecular Modeling and Statistical Analysis
Current Pharmaceutical Design